STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Company

Ernexa Therapeutics Inc.

Filed

December 5, 2022

Period of Report

December 2, 2022

Accession Number

0001062993-22-023351